[Our experience with the application of triethylene melamine (TEM) in patients with malignant hemopathies].
D007938:Leukemia / Q000628:therapy*; D007945:Leukemia, Lymphoid / Q000628:therapy*; D008223:Lymphoma; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy*; D014265:Triethylenemelamine / Q000628:therapy*
D014265:Triethylenemelamine
LEUCOSARCOMA/therapy; LEUKEMIA, LYMPHOCYTIC/therapy; LYMPHOSARCOMA/therapy; TRIETHYLENE MELAMINE/therapy